Mofegiline Hydrochloride

N/A

Report date: 2022/05/12 17:20:35

NME

Base Information

Drug NameMofegiline Hydrochloride

Drug Alias Name盐酸莫非吉兰mofegilina莫非吉非mofegilinumMDL-72974 +[6]

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionMonoamine oxidase B inhibitors

TargetsMonoamine oxidase B

Therapy Area/IndicationsParkinson Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 3 Clinical)

Highest Status in ChinaN/A

Originator CompaniesSanofi

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesSanofi

Active IndicationsN/A

Inactive IndicationsParkinson Disease

ATC CodeN/A